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Mucins are the structural components of the epithelial mucose that protects the respiratory, gastrointestinal 
and reproductive tracts from the hostile environments, including microorganisms, toxim and abrasives. 
Mucins constitute a group of high molecular weight (> 200 kDa), polydisperse and highly glycosylated 
proteins which are present on the surface of most epithelial tissues. Our understanding of the structure and 
function of mucins has advanced significantly in the last decade. This progress was mainly associated with 
the isolation of the cDNA clones, encoding a family of epithelial mucins. To date, this family includes 
eight mucin genes (MUCJ—MUC8) and more await to be discovered. Based on sequence analysis and 
studies of subcellular localisation, epithelial mucins could be divided into two classes: membrane-associated 
(MUC1) and secretory (MUC2-8). This review is focused on our current knowledge of the structure of 
products of mucin genes and their function in normal tissues and in disease. The regulation of the 
expression of mucin genes, posttranslational modifications and alterations in secretion and processing will 
also be discussed. 
Mucins as an integral part of mucus. Most mam­
malian epithelia that are in contact with hostile 
environments need protection, which is provided by 
secretion of a mucus gel. Specialised epithelial cells, 
such as goblet and non-goblet cells, secrete mucus 
which adheres to the epithelial surface and serves to 
hydrate and protect the underlying epithelium and 
also to trap foreign substances for their removal [1, 
2]. Mucus can be characterised as a slimy, viscous 
secretion that contains water, minerals, immuno­
globulins, and mucins. The specific properties of 
mucus vary among the different tissues, but there are 
some common features which include both physical 
aspects such as lubrication, protection and chemical 
composition. Mucins make up a large part of the 
mucus and contribute to its viscosity, elasticity, and 
protective functions. 
Structural and functional diversity of mucin ge­
nes. Mucins constitute a heterogeneous group of high 
molecular weight (> 200 kDa) glycoproteins which are 
present on the surface of most epithelial cells [ 1 , 3 , 
4]. Biochemical characterisation of mucins, purified 
from different tissues, indicated that these molecules 
are heavily glycosylated and, in some cases, contain 
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more then 75 % of carbohydrates by weight [5 J, On 
the basis of their sensitivity to proteolytic enzymes, 
the existence of so called «naked regions» that are 
devoid of carbohydrates was demonstrated. It was 
also found that sugar groups are mainly linked to the 
protein backbone via O-glycosidic bonds, formed 
between N-acetylgalactosamine and serine or thre­
onine residues {3 J. 
In general, mucins are difficult to analyse by 
conventional biochemical and biophysical methods, 
due to their large size and high degree of glyco-
sylation. However, cDNA cloning and sequencing of 
mucin genes unfolded considerable insight into the 
primary structure and, subsequently, the function of 
these molecules. 
The first mucin gene, called MUC1, was iden­
tified in 1987 [6]. To date, eight different mucin 
genes have been cloned (MUC1—MUC8) and more 
await to be discovered [7—16]. Due to the high level 
of heterogeneity and presence of numerous carbo­
hydrate chains on mucin polypeptide backbones, they 
have proven to be difficult for protein sequencing 
analysis. As a result of that, most mucin genes were 
cloned by screening of expression libraries with 
polyclonal and monoclonal antibodies, raised against 
purified and chemically deglycosylated mucins. No 
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sequence homology was revealed between mucin genes 
from the analysis of corresponding cDNA clones, but 
common features of the internal organisation of the 
polypeptide backbone were uncovered [3, 4] . 
First of all, a major portion of each mucin gene 
was found to consist of tandem repeats, which are 
specific for each type of mucin. Secondly, serine and 
threonine residues, located within the tandem re­
peats, create potential glycosylation sites. Thirdly, 
the high degree of heterogeneity can be explained by 
a variable number of tandem repeats and different 
glycosylation patterns. Finally, the alternating pattern 
of hydrophylic and hydrophobic domains was found. 
Tandem repeat sequences. Tandem repeats of 
mucin genes are not homologous to each other in 
sequence and differ significantly in length. For exa­
mple, the MUC5AC gene product contains the shor­
test repeat structure of 8 amino acids, while the 
MUC6 gene product has the longest repeat unit of 169 
amino acids [11, 12]. A summary of the mucin 
tandem repeats and their amino acid composition is 
presented in Table 1. 
Among these differences, mucin tandem repeats 
have one common feature — a high percentage of 
three amino acids: serine, threonine and proline. 
These three amino acids together constitute 20— 
55 % of mucin tandem repeats. The serine and 
threonine residues of tandem repeats are potential 
glycosylation sites, through which hundreds of oligo­
saccharide chains may attach to a single core protein. 
It has been proposed that proline residues in 
tandem repeats may play a structural role, since this 
amino acid is known to be involved in the formation 
of the a-turn left-handed helixes, which exhibit rigid 
rod-like structures [17]. The presence of proline 
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residues near serine and threonine, particularly at 
position -1 and +3, was shown to be important for the 
initiation of O-glycosylation of mucins [17]. 
Electron microscopy revealed native mucin mole­
cules as long filamentous structures, varying in length 
from 200 to > 1000 nm [18]. Profound glycosylation 
and presence of a large number of proline residues in 
tandem repeats may determine the filamentous confo­
rmation of mucin molecules, observed by electron 
microscopy. Significant variability in the size of mucin 
molecules can be explained by the variable number of 
tandem repeats and polymerisation of subunits. 
The arrangement of the mucin subunits in the 
mucus is also controversial. Several structural models 
have been proposed, including end-to-end attachment 
of mucin subunits by disulphide bridges and a 
flexible-thread model with or without the linking 
peptide [1, 19]. 
Glycosylation of mucins. Glycosylation of mucins 
take place in the ds-Golgi compartments and is 
subsequently followed by sialynation and sulphation 
[5]. Attached oligosaccharide chains differ in length: 
from 1 to 20 sugars per chain. It has also been 
demonstrated that the number and composition of 
associated oligosaccharides varies between different 
mucins which may explain the inherent heterogeneity 
of these molecules. Interestingly, the same mucins 
contain different oligosaccharide chains in different 
tissues and their composition is altered in diseases 
[20—22 ]. 
Sequence analysis of mucin genes show the 
presence of potential N-glycosylation sites. Xu et al. 
[23] identified N-glycosylation of rat intestinal mucin 
(RIM) by chemical analysis and suggested that this 
modification may play a role in the intracellular 
Table J 
Characterisation of tandem repeats of the mucin gene products 
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targeting of mucin. In another study, N-glycosylation 
was shown to be important for the oligomerisation of 
gastric mucin [24 ]. However, more studies are neces­
sary to clarify the importance of this posttranslational 
modification in mucin function. 
Based on the composition of attached groups, 
mucins can be divided into three main classes: 
sialomucins (acidic mucins), sulfomucins (very acidic 
mucins) and neutral mucins, containing mainly hexo-
ses. These different subclasses of mucins can be 
easily distinguished from each other by special histo-
chemical analysis. 
Membrane-associated and secretory mucins. Ba­
sed on the structure and cellular localisation, epi­
thelial mucins can be subdivided into membrane-
associated (MUC1) and secretory (MUC2—-MUC8), 
as shown in Fig. 1. 
MUC1 is the only cloned membrane-associated 
mucin which consists of a large highly glycosylated 
extracellular domain, a membrane spanning domain, 
and a short cytoplasmic domain [6 ]. It has also been 
demonstrated that MUC1 is not able to form oligo-
meric complexes, which are specific for secretory 
mucins [25]. The extracellular domain — extends 
well above the apical cell membrane and this can be 
important for specific function of this mucin. Mem­
brane association of the MUC1, observed by im-
munohistochemical analysis, could be explained by 
the presence of a hydrophobic membrane-spanning 
domain. The function of the cytoplasmic domain is 
not known, but it has been suggested that this domain 
may provide a link with the actin cytoskeleton [26]. 
MUC1 mucin is expressed in nearly all epithelial 
tissues. Attention has recently focused on the aber­
rant expression of MUC1 by carcinomas of different 
origins, which makes it an important marker in cancer 
[27—29]. 
Secretory mucins constitute the viscous mucus of 
the tracheobronchial, gastrointestinal, and reproduc­
tive tracts and typically form extremely large oligo­
mers through linkage of protein monomers via disul­
fide bridges. Complete cDNA sequences are available 
only for two secretory mucins: MUC2 and MUC7 [7, 
9] . The cDNAs for MUC5A, B, and С were originally 
cloned from human tracheobronchial mucosa cDNA 
libraries [8, 11]. Chromosomal mapping has demon­
strated that MUC5A and MUC5C are part of the 
same gene [30] and therefore were termed as 
MUC5AC. The presence of specific regions at the 
N-terminus, called leader sequences, determines their 
extracellular localisation. Besides the tandem repeat 
sequences, secretory mucins (MUC2, MUC5AC) were 
shown to contain a cyctein-rich domains [7, 11]. 
These domains are known to be important in 
mediating protein-protein interactions via the 
formation of disulfide bridges. The identification of 
cystein-rich domains in secretory type of mucins may 
explain the polymerisation of mucin molecules into 
gel. It is interesting that MUC7 lacks cystein-rich 
domain and is not able to form oligomers. This 
secretory mucin was found to be expressed only in 
submandibular salivary gland, but not all epithelial 
tissues have been analysed [9]. Cloning and charac­
terisation of the full length cDNAs for other secretory 
MEMBRANE-BOUND 
MUCIN 
MUC1 
SECRETORY 
MUCINS 
MUC2-MUC8 
END0THELIUM/LEUKOCYTE-
ASSOCIATED MUCINS 
MEMBRANE-BOUND 
CD34, CD43, GlyCAM, 
PSGL-1, TACTILE 
Fig. 1. Classification of mucins, based on the structure and tissue expression 
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mucin genes (MUC3, MUC4, MUC6, and MUC8) is 
essential for the elucidation of their function. 
Schematic structures of the transmembrane 
(MUC1) and secretory mucins (MUC2) are shown in 
Fig. 2. 
Mucin-like molecules. Mucin-like proteins have 
been identified in non-epithelial tissues, such as 
endothelium and lymphocytes. Endothelial and leu­
kocyte type of mucins are membrane associated and 
heavily glycosylated proteins, involved in lymphocyte 
migration via specific binding to selectins [3]. It is 
suggested that mucin-like proteins play an important 
role in inflammation via the initiation of the adhesion 
cascade and lymphocyte activation [31 J. 
Expression of mucin genes and its regulation. 
Initial analysis of mucin gene expression by immuno-
histological methods was not very productive, because 
of the lack of specific antibodies directed against these 
Cysteine-rich 
domain 
^ - N-iinlced oligosaccharides 
£ - О-iinked oligosaccharides 
S-S - disulfide bonds 
Fig. 2. Schematic structures of the menbrane-bound (A) and secretory (B) mucins 
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proteins. Polyclonal and monoclonal antibodies raised 
against native mucins recognised mainly carbohydrate 
epitopes, which are difficult to classify and not just 
expressed ол mucins. The use of chemically deglyco-
sylated and recombinant (unglycosylated) mucins as 
antigens allowed generating of a panel of specific and 
high affinity antibodies [32]. 
The availability of specific antibodies and also 
cDNA probes enabled significant analysis of mucin 
gene expression in mammalian epithelia. Different 
techniques have been employed to fulfil this aim, 
including Northern and Western blot analysis, immu-
nohistochemistry, RT-PCR and in situ hybridisation. 
Numerous studies provided evidence that mucins 
are expressed in an extremely tissue-specific manner. 
Mucin transcripts and proteins have only been detec­
ted in epithelial tissues [6, 7, 9, 33, 34, 50—56], 
Differential expression of mucin genes in various 
epithelial tissues has also been observed. For exa­
mple, MUC1 and MUC5B exhibit a widespread 
pattern of expression and are detected in all or almost 
all epithelial tissue. On the other hand, MUC7 has so 
far found to be expressed only in submandibular 
salivary glands [9]. A summary of mucin gene 
expression in different human epithelial tissues is 
presented in Table 2. 
Aberrant overexpression of mucin genes has been 
also detected in patients with cystic fibrosis, asthma 
and chronic bronchitis [21, 35]. Abnormal expression 
of mucin, was demonstrated in skin fibroblasts, 
derived from a patient with long-standing sclero­
derma. Histological examination of a biopsy specimen 
from the affected skin indicated significant accu­
mulation of mucin between collagen bundles [36 ]. 
The understanding the mechanisms of tissue-
and cell type-specific expression of mucin genes 
remains a topic of intense research. Developmental 
expression of mucin genes was shown to correlate well 
with the differentiation of epithelial cells in mammary 
glands, gastrointestinal and respiratory tracts [37, 
38 ]. 
Many endogenous and exogenous factors, in­
cluding growth factors and hormones, pathogenic 
organisms and chemicals, were found to influence 
expression of mucin genes. For example, expression 
of MUC1 in mammary glands was found to be 
Table 2 
Expression of mucin genes in human epithelial tissues 
Level of expression: (+++) — high, (++) — medium, (+) — low, (—) — not expressed, (ND) — not determined 
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stimulated by insulin, prolactin and hydrocortisone 
[39]. In another study, it was shown that EGF can 
regulate differentiation of tracheal epithelial cells and 
subsequently stimulate expression of mucins [40]. 
Interestingly, an increased expression of EGF and its 
functional analogue TGFa has been demonstrated in 
response to the inflammatory process or tissue injury, 
which also induce mucin expression. On the other 
hand, vitamin A, which is known as an important 
factor in the regulation of airway epithelial cell 
function, exhibits an opposite effect on mucin exp­
ression. Both time- and dose-dependent downre-
gulation of MUC2 expression by vitamin A has 
recently been reported in tracheobronchial epithelial 
cells [41 ]. Taken together, these data indicate that 
the expression of mucin genes can be regulated in 
both a stimulatory and an inhibitory fashion. 
Differential expression of mucin genes, induced 
by various stimuli, has also been reported. Estrogen 
and dexamethasone were found to increase MUC4 
and MUC5 expression in human epithelial cell lines 4 
fold, but not MUC1 [42]. In the same study, it was 
shown that progesterone does not exhibit a sti­
mulatory effect. It was also demonstrated that dif­
ferential expression of mucin genes depends on the 
growth and differentiation of various subpopulations 
of mucus-secreting epithelial cell lines [43 ]. 
In a number of studies, it has been shown that 
viral or bacterial infections lead to a dramatic increase 
in mucin expression [44 ]. Irritation of mucous mem­
branes by chemicals also produces a stimulatory effect 
on the expression of mucin genes [45]. The molecular 
mechanism of this stimulation remains unclear. Re­
cently, it was demonstrated that inflammation-as­
sociated mediators stimulate mucin secretion in tra­
cheal epithelial cells via a mechanism, involving intra­
cellular production of nitric oxide, which serves as a 
signalling messenger [46 ]. 
Taken together these data indicate that exp­
ression of mucin genes is very complex and could be 
regulated at different levels, including transcription, 
alternative splicing and translation (schematic repre­
sentation in Fig. 3). 
Regulation at the level of transcription. Induced 
expression of different mucins in response to treat­
ment with various stimuli, was shown to require de 
novo RNA and protein synthesis, indicating trans­
criptional regulation of this process. Chromosomal 
mapping and sequence analysis of genomic clones has 
opened the field of transcriptional regulation of mucin 
genes. Promoter sequences, identified within the 
MUC1 and MUC5B genes, greatly facilitated affinity 
purification and characterisation of transcription fac­
tors, involved in the regulation of mucin genes [47, 
Fig. 3. Regulation of the expression of epithelial mucins 
48]. A nuclear protein, called NF1-MUC5B, was 
found to modulate the transcriptional activity of the 
mucin MUC5B gene [47 ]. Further characterisation of 
the new promoter regions in other mucin genes will 
create the platform for the discovery of common and 
specific transcription factors, involved in transcrip­
tional regulation of mucin genes. 
Heterogeneity of mucin mRNA. Polydispersity of 
the messenger RNA, which is a characteristic of most 
mucins, with the exception of MUC1, may also 
contribute to the regulation of their expression pattern 
[49]. Many factors can contribute to the hetero­
geneity of mucin messages. Firstly, rapid turnover of 
mucin RNA, confirmed experimentally by using the 
pulse-chase technique, is one of the most likely 
explanations of the observed polydispersity. Several 
destabilising sequences have been found within the 
3' untranslated region of mucin RNAs, which may at 
least in part explain their instability. It is known that 
nuclear and cytoplasmic proteins can specifically bind 
to these sequences and induce a rapid degradation of 
mucin RNA. 
Secondly, an alternative splicing of mucin 
mRNAs has also been suggested as a contributing 
factor. However sequence analysis of many mucin 
cDNA clones did not provide sufficient evidence in 
favour of this explanation. Alternatively, susceptibility 
to RNAase degradation and physical instability of 
very large mucin messages (well over 10.000 bases), 
may be an essential factor in generating an artifactual 
ladder of degraded mRNAs [10]. This hypothesis 
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could be ruled out by data indicating that poly-
dispersity of mucin mRNAs is also observed in the 
RNA samples, which showed no sign of degradation. 
Taken together, these results suggest that rapid 
turnover of mucin mRNAs seems the most likely 
explanation of polydispersity. Regulation of mucin 
mRNA stability by intracellular factors is going to be 
the subject of intense investigation in the near future. 
Regulation at the translational level There are 
some data indicating that restriction of mucin exp­
ression to mucous cells is regulated at the level of 
translation [37]. This conclusion was based on the 
analysis of MUC2 and MUC3 expression in human 
bronchus, where mRNAs specific for these mucins 
were found both in mucin-expressing and mucin-non-
expressing cells. So far, there are no data concerning 
the regulation of mucin gene expression at the 
post-translational level. 
Conclusion. The last decade has been very pro­
ductive and exciting in the study of mucin genes and 
their products. Isolation and sequence analysis of 
cDNA clones encoding eight mucin genes, provided 
insights into the structure of their products. Based on 
these studies, common features of the internal organi­
sation of the polypeptide backbone was uncovered 
within the family of epithelial mucins. The availability 
of cDNA clones has opened new areas of research on 
mucins. Immunohistochemical and in situ hybridi­
sation experiments with specific antibodies or cDNA 
probes provided the information on tissue distribution 
and subcellular localisation of the different mucin 
gene products. Expression studies of mucins in vitro, 
using cDNAs and cell lines, have also been initiated 
and should generate data which will enable better 
understanding of their role in physiological and 
pathological processes. However, much work remains 
to be done in elucidating the regulation of mucin gene 
expression. In order to examine this at the molecular 
level, the sequences of the mucin gene promoters have 
to be determined. The next few years will witness 
new insights into the research on mucins, especially 
with the generation of transgenic mice in which a 
particular mucin gene will be inactivated or over-
expressed in epithelial tissues. 
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Структура і функції епітеліальних муцинів 
Резюме 
Муцини — це структурні компоненти епітеліального шару 
мукози, які захищають респіраторний, травний та репродук­
тивний тракти від негативних впливів зовнішнього оточення 
(мікроорганізмів, токсинів та хімічних або механічних под­
разників). Муцини складають групу високо молекулярних (> 200 
кДа), полідисперсних та сильноглікозійованих білків, що знахо­
дяться на поверхні більшості епітеліальних тканин. За ос­
таннє десятиріччя прогрес в розумінні структури та функцій 
муцинів, в основному, пов'язаний з одержанням кДНК клонів, 
кодуючих сімейство епітеліальних муцинів. На сьогодні це 
сімейство охоплює вісім муцинових генів (MUC1—MUC8) і 
очікується відкриття нових. Базуючись на первинній струк­
турі та вивченні внутрішньоклітинної локалізації, епіте­
ліальні муцини можна поділити на два класи: мембран-асо-
ційовані (MUCJ) та секреторні (MUC2—MUC8). Цей огляд 
сфокусовано на сучасних уявленнях про структуру продуктів 
муцинових генів та їхні функції в нормальних тканинах і при 
патологіях. Обговорюються також регуляція експресії муци­
нових генів, посттрансляційні модифікації та зміни в секреції 
і процссингу. 
И. И. Рут 
Структура и функции эпителиальных муцинов 
Резюме 
Муцины — структурные компоненты эпителиального слоя 
мукозы — защищают респираторный, пищеварительный и ре­
продуктивный тракты от отрицательного воздействия внеш­
него окружения, включающего микроорганизмы, токсины и 
механические раздражители. Муцины составляют группу вы­
сокомолекулярных (> 200 к Да) полидисперсных и силыюглико-
зилированных белков, расположенных на поверхности большин­
ства эпителиальных тканей. За последнее 10-летие прогресс в 
выяснении структуры и функции муцинов был связан, в 
основном, с выделением кДНК клонов, кодирующих семейство 
эпителиальных муцинов. На сегодня это семейство включает 
уже восемь муцииовых генов (MUCJ—MUC8) и ожидается 
открытие новых. На основе анализа первичной структуры и 
изучения внутриклеточной локализации эпителиальные муци­
ны можно разделить на два класса: мембран-ассоциированные 
(MUC1) и секреторные (MUC2—MUC8). Данный обзор сфоку­
сирован на современных представлениях о структуре продук­
тов муциновых генов и их функциях в нормальных тканях и 
при патологиях. Обсуждаются также регуляция экспрессии 
муциновых генов, посттрансляционные модификации и изме­
нения в секреции и процессинге муцинов. 
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